[Immunostimulants--therapeutic aspects].
A survey is given about the so far known mode of action and the therapeutic application of the following agents with immunostimulatory effects: Interleukin-2, Interferon-gamma, Tumor necrosis factor, Thymosin alpha 1, Thymopentin, Splenopentin, Thymulin, Thymostimulin, Muramyl dipeptide, Bestatin, Tuftsin and Levamisole. The treatment of patients suffering from immunodeficiency disorders and cancer with such agents seems to be possible in the near future.
Diezel
W
W
Klinik und Poliklinik für Hautkrankheiten, Humboldt-Universität zu Berlin.
Volk
H D
HD
Daniel
V
V
Gruner
S
S
Sönnichsen
N
N
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007930:Leucine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use; D014405:Tuftsin / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D007376:Interleukin-2; D013951:Thymus Hormones; D014409:Tumor Necrosis Factor-alpha; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D007371:Interferon-gamma; D007930:Leucine; C012211:ubenimex; D014405:Tuftsin
Immunostimulantien--Therapeutische Aspekte.